Approximately 60% of women will experience a UTI in their lifetime2 — Flush Advanced+ helps to reduce the risk of recurrent ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its fourth-quarter and full-year 2025 ...

Arcus’s highest priority is to execute on its ongoing Phase 3 trial and overall development plan aimed at establishing casdatifan as the standard-of-care and backbone therapy for clear cell renal cell ...

Service expansions accelerate pharmacy’s achievement of 2 million shipments while maintaining industry-leading patient ...

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced the dates and times of quarterly conference calls ...

Exclusive agreement covers 13 Central and Eastern European marketsCollaboration will help expand access to VANFLYTA for ...

Locus Biosciences today announced a contract award from the National Institute of Allergy and Infectious Diseases (NIAID), ...

U.S. IND represents the second regulatory clearance for KLN-1010 and enables the first multi-center clinical trial in the U.S ...

Merck (known as MSD outside of the United States and Canada) will complete its $9.2 billion acquisition of Cidara ...

Veteran trial lawyer among 102 attorneys honored nationwide for 2026HOUSTON--(BUSINESS WIRE)--Iconic Houston trial lawyer Mark Lanier has been inducted into the Lawdragon Hall of Fame class of ...

Bringing Decades of Successful Biotech Company Growth, Financing, IPO and M&A ExpertiseNORFOLK, Va.--(BUSINESS WIRE)--ReAlta ...

Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire ...